AU7470300A - Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof - Google Patents

Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof

Info

Publication number
AU7470300A
AU7470300A AU74703/00A AU7470300A AU7470300A AU 7470300 A AU7470300 A AU 7470300A AU 74703/00 A AU74703/00 A AU 74703/00A AU 7470300 A AU7470300 A AU 7470300A AU 7470300 A AU7470300 A AU 7470300A
Authority
AU
Australia
Prior art keywords
pilus
crystals
adhesion
activity
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74703/00A
Inventor
Klaus Fuetterer
Scott J. Hultgren
Frederic G. Sauer
Gabriel Waksman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU7470300A publication Critical patent/AU7470300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU74703/00A 1999-08-11 2000-08-11 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof Abandoned AU7470300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14828099P 1999-08-11 1999-08-11
US60148280 1999-08-11
PCT/US2000/022087 WO2001010386A2 (en) 1999-08-11 2000-08-11 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof

Publications (1)

Publication Number Publication Date
AU7470300A true AU7470300A (en) 2001-03-05

Family

ID=22525074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74703/00A Abandoned AU7470300A (en) 1999-08-11 2000-08-11 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof

Country Status (2)

Country Link
AU (1) AU7470300A (en)
WO (1) WO2001010386A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100378223C (en) * 2003-04-17 2008-04-02 南方医院 Pylorus screw bacterium fenestra element having adhesion function
US7544773B2 (en) 2003-07-14 2009-06-09 Timo Kalevi Korpela Antimicrobials against pathogenic bacteria and method for screening them
US7976851B2 (en) 2005-07-22 2011-07-12 The Regents Of The University Of Colorado, A Body Corporate Non-toxic biofilm inhibitor
WO2012109263A1 (en) 2011-02-07 2012-08-16 The Washington University Mannoside compounds and methods of use thereof
ES2959183T3 (en) 2013-05-30 2024-02-21 Washington University St Louis Mannose derivatives and their use in the treatment of bacterial infections
MX2018001964A (en) * 2015-08-24 2018-06-19 Medimmune Llc Mrka polypeptides, antibodies, and uses thereof.
WO2017165619A1 (en) 2016-03-23 2017-09-28 Fimbrion Therapeutics, Inc. Mannose-derived antagonists of fimh useful for treating disease
CA3105940A1 (en) 2018-07-10 2020-01-16 Glaxosmithkline Intellectual Property Development Limited C-mannoside compounds useful for the treatment of urinary tract infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882425A (en) * 1987-07-09 1989-11-21 Baylor College Of Medicine Receptor specific proteins and their use in receptor typing
WO1995014028A2 (en) * 1993-11-18 1995-05-26 Washington University Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections

Also Published As

Publication number Publication date
WO2001010386A2 (en) 2001-02-15
WO2001010386A3 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2002251266A1 (en) Inhibitors of akt activity
EP1494676A4 (en) Fused quinoxaline derivatives as inhibitors of akt activity
AU3874200A (en) Monitoring of individual internet usage
AU7603300A (en) Sterilization of fire sprinkler systems
AU2268301A (en) Novel urea compounds, compositions and methods of use and preparation
AU2002362030A1 (en) Methods for inhibiting deacetylase activity
AU2002228317A1 (en) Benz-1,3-azole derivatives and their uses as heparanase inhibitors
AU3365401A (en) Use of ketotifen as ophthalmic agent
AU2208401A (en) Inhibitors of complement activation, their preparation and use
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
AU2003240668A1 (en) Attenuation of metapneumovirus
HUP0200092A3 (en) Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active betha-3 agonist by the use of the same
AU7470300A (en) Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
AU2003282575A1 (en) Activity-based probes, and methods of their preparation and use
AU1929301A (en) Methods of use of peptide deformylase inhibitors as novel antibacterial agents
AU6406800A (en) SF3 promoter and methods of use
AU1651001A (en) Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AUPR790901A0 (en) Inactivation of papillomavirus
AU2002246585A1 (en) Plant promoters, and methods of use
AU6533700A (en) Methods of gene expression monitoring
AU4021700A (en) Methods of use of beta1-integrin inhibitors
AU2002340237A1 (en) Methods of inhibiting osteoclast activity
AU7709400A (en) Methods of use of fluoroquinolone compounds against bacteria
AU6947900A (en) Methods of use of fluoroquinolone compounds against bacteria

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase